Research map: Long‐acting monoclonal antibodies and the evolving landscape of infant respiratory syncytial virus prevention

Back to the article

Papers in this map

  1. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants · Laura L. Hammitt · 2022 · 1053 citations · Cited by this paper
  2. Evaluating anger in Chinese adolescents: Psychometric validation and clinical sensitivity of the Chinese version of the Children's Inventory of Anger · 2025 · Related
  3. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants · Beate Kampmann · 2023 · 1005 citations · Cited by this paper
  4. CRPPA exon 6–9 deletion as a founder mutation in Chinese patients with dystroglycanopathy · 2025 · Related
  5. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants · M. Pamela Griffin · 2020 · 785 citations · Cited by this paper
  6. Sex‐specific associations between hypertensive disorders in pregnancy and fetal and placental weight · 2025 · Related
  7. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants · Simon B. Drysdale · 2023 · 389 citations · Cited by this paper
  8. Large‐language‐models for pediatric diagnosis: Performance evaluation using real‐world clinical notes from common and rare cases · 2026 · Related
  9. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 · Jefferson M. Jones · 2023 · 368 citations · Cited by this paper
  10. Corneal characteristics in children with Marfan syndrome with or without ectopia lentis · 2025 · Related
  11. Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh · Helen Y. Chu · 2014 · 193 citations · Cited by this paper
  12. Long‐term outcomes of haploidentical hematopoietic stem cell transplantation with antithymocyte globulin–based myeloablative conditioning in pediatric refractory or relapsed non‐Hodgkin lymphoma · 2026 · Related
  13. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children · Luis Garegnani · 2021 · 172 citations · Cited by this paper
  14. Retrospective evaluation of palliative care consultation in critically ill adult and pediatric cancer subjects · 2026 · Related
  15. Clesrovimab for Prevention of RSV Disease in Healthy Infants · Heather Joy Zar · 2025 · 81 citations · Cited by this paper
  16. Epidemiology and the cost burden of hospitalized pediatric‐onset inflammatory bowel disease in China: A national database study · 2025 · Related
  17. Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life · Andrea G. Buchwald · 2020 · 80 citations · Cited by this paper
  18. Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024 · Heidi L. Moline · 2024 · 68 citations · Cited by this paper
  19. Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak · Natasha Halasa · 2023 · 59 citations · Cited by this paper
  20. Estimated Effectiveness of Nirsevimab Against Respiratory Syncytial Virus · Hanmeng Xu · 2025 · 57 citations · Cited by this paper
  21. Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates · Christine A Blauvelt · 2025 · 37 citations · Cited by this paper
  22. Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis · Daira Trusinska · 2025 · 33 citations · Cited by this paper
  23. Maternal Immunization With RSVpreF Vaccine: Effectiveness in Preventing Respiratory Syncytial Virus–associated Hospitalizations in Infants Under 6 Months in Argentina: Multicenter Case–control Study · Ángela Gentile · 2025 · 31 citations · Cited by this paper
  24. Enhanced placental antibody transfer efficiency with longer interval between maternal respiratory syncytial virus vaccination and birth · Olyvia J. Jasset · 2024 · 28 citations · Cited by this paper
  25. Clesrovimab in Infants and Children at Increased Risk for Severe RSV Disease · Heather Joy Zar · 2025 · 24 citations · Cited by this paper
  26. Acceptance and safety of the RSV-preventive treatment of newborns with nirsevimab in the maternity department: a prospective longitudinal cohort study in France · Charlotte Ocana de Sentuary · 2024 · 21 citations · Cited by this paper
  27. Sociodemographic Characteristics of Infants Receiving Nirsevimab · Salomé Boutin · 2025 · 10 citations · Cited by this paper
  28. Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France · Slim Fourati · 2025 · 10 citations · Cited by this paper
  29. Parental Socioeconomic Status and an Infant’s Risk of Hospital Admission for Respiratory Syncytial Virus · Karoliina Koivisto · 2024 · 9 citations · Cited by this paper
  30. Nirsevimab Uptake in a Pediatric Primary Care Network During the 2023-2024 RSV Season · Sarah Schaffer DeRoo · 2025 · 9 citations · Cited by this paper
  31. The impact of nirsevimab prophylaxis on RSV hospitalizations: a real-world cost-benefit analysis in Tuscany, Italy · Vieri Lastrucci · 2025 · 8 citations · Cited by this paper
  32. ESCMID Global Abstract Book 2025 · Laudazzi, Martina · 2025 · 6 citations · Cited by this paper
  33. Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration · María Iglesias‐Caballero · 2025 · 5 citations · Cited by this paper
  34. Monitoring effectiveness of nirsevimab immunization against RSV hospitalization using surveillance data: a test-negative case–control study, Spain, October 2024–March 2025 · Sandra Campos Mena · 2025 · 4 citations · Cited by this paper
  35. The S190R mutation in RSV-A F protein impairs nirsevimab binding and neutralization capacity · Sapir Cordela · 2026 · 2 citations · Cited by this paper
  36. Efectividad de la inmunización con nirsevimab en neonatos para prevenir hospitalizaciones por virus respiratorio sincitial durante dos temporadas en Navarra · Noelia Vera-Punzano · 2025 · 1 citation · Cited by this paper
  37. Multi-Hospital Pediatric Surge Response to an RSV Epidemic in a US State: Oregon, 2022 · Brendan Cleary · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)